Identification of prognostic factors and surgical indications for metastatic gastric cancer

49Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The treatment of metastatic gastric cancer is not uniform, and the prognostic factors and indications for surgery are currently unclear. This retrospective study aimed to identify the prognostic factors and clinical indications for surgery in patients with metastatic gastric cancer.Methods: A total of 123 consecutive patients with gastric cancer and synchronous distant metastasis treated between January 1999 and December 2011 were reviewed. Patient, tumor, laboratory, surgical, and chemotherapy factors were analyzed, with overall survival as the endpoint. Univariate analyses were performed using the log-rank test, multivariate analyses were performed using the Cox proportional hazards model, and Kaplan-Meier curves were used to estimate survival. Significance was set at p < 0.05.Results: The median overall survival time was 13.1 months. Ninety-eight patients received chemotherapy. Twenty-eight patients underwent gastrectomy with metastasectomy and 55 underwent gastrectomy without metastasectomy. The median overall survival time for patients who underwent gastrectomy with metastasectomy, gastrectomy without metastasectomy, and no surgical intervention was 21.9 months, 12.5 months, and 7.2 months, respectively (p < 0.001). Multivariate analysis identified gastrectomy with or without metastasectomy, performance status (PS) ≥3, neutrophil-to-lymphocyte ratio (NLR) >3.1, and carbohydrate antigen 19-9 (CA19-9) level >37 U/mL as predictors of poor survival. NLR and CA19-9 level were also independent prognostic factors in the group of patients who underwent surgery.Conclusions: High pretreatment NLR, CA19-9 level, and PS are predictors of poor prognosis in patients with metastatic gastric cancer. In selected patients, gastrectomy can be performed safely, and may be associated with longer survival. © 2014 Mohri et al.; licensee BioMed Central Ltd.

References Powered by Scopus

Global cancer statistics

31577Citations
N/AReaders
Get full text

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1916Citations
N/AReaders
Get full text

Colorectal carcinoma antigens detected by hybridoma antibodies

1240Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies

220Citations
N/AReaders
Get full text

Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: A systematic review and meta-analysis

93Citations
N/AReaders
Get full text

The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis

82Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mohri, Y., Tanaka, K., Ohi, M., Saigusa, S., Yasuda, H., Toiyama, Y., … Kusunoki, M. (2014). Identification of prognostic factors and surgical indications for metastatic gastric cancer. BMC Cancer, 14(1). https://doi.org/10.1186/1471-2407-14-409

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

71%

Researcher 3

21%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 14

82%

Biochemistry, Genetics and Molecular Bi... 1

6%

Environmental Science 1

6%

Psychology 1

6%

Save time finding and organizing research with Mendeley

Sign up for free
0